Timo L. M. ten Hagen
Department of Surgical Oncology
University Hospital Rotterdam/Daniel den Hoed Cancer Center
Rotterdam
Netherlands
Name/email consistency: high
- Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil) in soft tissue sarcoma-bearing rats. ten Hagen, T.L., Seynhaeve, A.L., van Tiel, S.T., Ruiter, D.J., Eggermont, A.M. Int. J. Cancer (2002)
- Low-dose tumor necrosis factor-alpha augments antitumor activity of stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing rats. Ten Hagen, T.L., Van Der Veen, A.H., Nooijen, P.T., Van Tiel, S.T., Seynhaeve, A.L., Eggermont, A.M. Int. J. Cancer (2000)
- Involvement of T cells in enhanced resistance to Klebsiella pneumoniae septicemia in mice treated with liposome-encapsulated muramyl tripeptide phosphatidylethanolamine or gamma interferon. ten Hagen, T.L., van Vianen, W., Savelkoul, H.F., Heremans, H., Buurman, W.A., Bakker-Woudenberg, I.A. Infect. Immun. (1998)
- Differential nitric oxide and TNF-alpha production of murine Kupffer cell subfractions upon priming with IFN-gamma and TNF-alpha. ten Hagen, T.L., van Vianen, W., Heremans, H., Bakker-Woudenberg, I.A. Liver (1998)